The obesity paradox in beyond total mesorectal excision surgery for locally advanced and recurrent rectal cancer

Updates in Surgery
Daniel L H BairdParis P Tekkis

Abstract

The objective is to investigate preoperative body mass index (BMI) in patients receiving beyond total mesorectal excision (bTME) surgery. The primary end point is length of postoperative stay. Secondary end points are length of intensive care stay, postoperative morbidity and overall survival. BMI is the most commonly used anthropometric measurement of nutrition and studies have shown that overweight and obese patients can have improved surgical outcomes. Patients who underwent a bTME operation for locally advanced or recurrent rectal cancer were put into three BMI (kg/m2) groups of normal weight (18.5-24.9), overweight (25-29.9) and obese (≥ 30) for analysis. Included are 220 consecutive patients from a single centre. The overall length of stay, in days ± standard deviation (range), for normal weight, overweight and obese patients was 21.14 ± 16.4 (6-99), 15.24 ± 4.3 (7-32) and 19.10 ± 9.8 (8-62) respectively (p = 0.002). The mean ICU length of stay was 5.40 ± 9.1 (1-69), 3.37 ± 2.4 (0-19) and 3.60 ± 2.4 (1-14), respectively (p = 0.030). There was no significant difference between the three groups in terms of postoperative morbidity or overall survival. Patients with a normal weight BMI in this cohort have a significantly long...Continue Reading

References

Apr 9, 1994·BMJ : British Medical Journal·J P McWhirter, C R Pennington
Apr 14, 1999·Kidney International·E FleischmannA K Salahudeen
Nov 24, 1999·Diseases of the Colon and Rectum·H J WaneboD E Wrobleski
Jun 6, 2000·Critical Reviews in Oncology/hematology·G Nitenberg, B Raynard
Feb 19, 2002·Journal of the American College of Cardiology·Luis GrubergJoseph Lindsay
Jul 20, 2002·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sheila B FettesChristopher R Pennington
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Aug 13, 2003·Current Opinion in Clinical Nutrition and Metabolic Care·Dan L Waitzberg, Maria Isabel T D Correia
Dec 12, 2003·Diseases of the Colon and Rectum·Ramon E JimenezW Douglas Wong
Jul 13, 2004·Wiener medizinische Wochenschrift·Meinolf Karthaus, Fabian Frieler
Jan 12, 2005·Archives of Internal Medicine·Jeptha P CurtisHarlan M Krumholz
Oct 18, 2005·Diseases of the Colon and Rectum·Arne E FaerdenArne Bakka
Oct 22, 2005·Gut·E E FrezzaM Chiriva-Internati
Jun 13, 2006·Journal of Clinical Epidemiology·Digant GuptaCarolyn A Lammersfeld
Aug 18, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Susanna C LarssonAlicja Wolk
Aug 24, 2006·The New England Journal of Medicine·Kenneth F AdamsMichael F Leitzmann
Aug 19, 2007·Journal of Gastroenterology·Seong-Eun KimIl Hwan Moon
May 1, 2009·Diseases of the Colon and Rectum·Gisella V SalernoGina Brown
May 8, 2009·World Journal of Surgery·F T J FerenschildJ H W de Wilt
Mar 27, 2010·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·A K GarthT C Crowe
May 22, 2010·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·S T BurdenC Todd
Jun 22, 2010·International Journal of Colorectal Disease·Laura A HealyJohn V Reynolds
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jan 13, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Charles MuellerUNKNOWN American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors
Jan 21, 2011·Current Cancer Drug Targets·Lidija Klampfer
May 15, 2013·Annals of Surgical Oncology·H M MohanD C Winter
Nov 10, 2013·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Paul J SpeicherJohn Migaly
Jun 5, 2014·American Journal of Epidemiology·Katherine M FlegalBarry I Graubard
Jul 15, 2015·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K KodedaA Martling
Aug 28, 2015·Journal of Surgical Oncology·Zhobin MoghadamyeghanehMichael J Stamos
Nov 4, 2015·Frontiers in Oncology·Paolo Giovanni VigneriLivia Manzella
Nov 10, 2015·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Kristin E Flegal, Cindy Lustig
Mar 20, 2016·JPEN. Journal of Parenteral and Enteral Nutrition·Gordon L Jensen
Jun 28, 2016·Techniques in Coloproctology·B DolemanG Gagliardi

❮ Previous
Next ❯

Citations

Nov 26, 2020·The Journal of Applied Laboratory Medicine·Okechukwu V NwogboGurmukh Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.